The novel optical, electrical, and magnetic properties of ultra-small inorganic nanoparticles make them 5 very attractive in diverse applications in the fields of health, clean and renewable energy, and environmental sustainability. This article comprehensively summarizes state-of-the-art fluorescence imaging using ultra-small nanoparticles as probes, including quantum dots, metal nanoclusters, carbon nanomaterials, up-conversion, and silicon nanomaterials.
Introduction

10
When the size of inorganic materials is reduced to the nanoscale range, they exhibit unusual optical, electrical, magnetic, mechanical, and chemical properties, distinctly different from those in their bulk analogues. For example, semiconductor nanocrystals (usually referred to as quantum dots (QDs)) exhibit 15 strong size-dependence of their optical properties when their size is smaller than the Bohr exciton radius. 1 Magnetic iron oxide nanoparticles become superparamagnetic when their size is reduced below the critical size where they behave as individual magnetic domains. 2 Carbon nanotubes show remarkable tensile 20 strength, 3 and graphene exhibits remarkably high electron mobility. 4 Their novel properties make these nanomaterials very attractive in diverse applications, ranging from energy conversion and storage to biomedical imaging. In this article, we summarize the recent advances in ultra-small inorganic nanoparticles for 25 fluorescence imaging (Table 1) , especially those smaller than 10 nm as they are easily taken up and excreted, and show longer blood circulation time in comparison with larger ones. For fluorescent materials, there are two kinds of photoluminescence mechanisms, i.e. down conversion and up 30 conversion. 5 The down-conversion process normally absorbs one high energy photon and emits a low energy photon, e.g. a Stokesshift emission. In contrast, up-conversion is an anti-Stokes process that converts the absorbed low energy light into higher energy emission via multiple absorptions or energy transfer 35 processes. The fluorescence generated by both processes has long been used in molecular imaging to visualize cell biology at many levels. 6, 7 The first fluorescence imaging could be dated back to 1924 when Policard observed red fluorescence from endogenous porphyrins in tumours illuminated with an ultraviolet light. 8 Since 40 then, advances in molecular biology, organic chemistry and material science have revealed several classes of promising probes for fluorescence imaging, which include small organic dyes, fluorescent proteins, and fluorescent inorganic nanoparticles. 6 Compared with organic dyes and fluorescent 45 proteins, fluorescent inorganic nanoparticles have several distinct advantages. For example, QDs have high absorbance, high QY, narrow emission, large Stokes shifts, and high resistance to photobleaching. 9 These properties render them robust for fluorescent probes for biolabelling and bioimaging. [9] [10] [11] [12] In recent 50 years, other fluorescent nanomaterials, such as ultra-small metal nanoclusters, fluorescent carbon and graphene dots, upconversion nanocrystals, and silicon nanoparticles have been exploited as alternatives to conventional QDs. In the following sections, we introduce these fluorescent nanomaterials from 55 viewpoints of preparation and functionalization to satisfy the requirements for routine labelling and imaging of cells and tissues. Advanced applications of fluorescent nanomaterials in living systems as sensors for enzyme, oxygen, metal ions, and pH, have readily been described elsewhere. 13-16 60 For bioimaging, fluorescent nanoparticles should have watersolubility, biocompatibility, chemical-and photo-stability. They should also have uniform size and high quantum yield (QY) for optimized brightness, narrow and symmetric emission for multiplexing and colour saturation, and minimized blinking for nanoparticles and fluorescence bioimaging. 
Semiconducting Fluorescent QDs
Synthesis of monodisperse QDs with high QYs
5
Fluorescent QDs include semiconducting nanoparticles from Groups IV (Si and Ge dots), [17] [18] [19] [20] II-VI (CdE and ZnE, E = S, Se, and Te), III-V (InP), and I-III-VI (CuInS 2 , CuInSe 2 ), [21] [22] [23] in which the II-VI QDs (especially CdSe and CdTe based QDs) have been extensively investigated as prototypes of semiconductor QDs due 10 to their strong quantum confinement effects and high fluorescence QYs. II-VI colloidal fluorescent QDs can be prepared in organic solvents or aqueous solutions. Organic routes are usually selected to prepare monodisperse and highly fluorescent QDs. Discovered in 1981, QDs did not receive 15 intensive attention until 1993, when a breakthrough in preparation of colloidal QDs in solution was achieved. 24 Monodisperse cadmium chalcogenide (CdE, E = S, Se, and/or Te) QDs were prepared by fast injection of a solution of precursors (organometallic Cd and Se/S/Te dissolved in 20 trioctylphosphine (TOP)) into a high-boiling-point (~ 300 °C) coordinating solvent trioctylphosphine oxide (TOPO). 24 These QDs had a narrow particle size distribution with 10% standard deviation, which was reduced to 5% after sizeselective precipitation. Their fluorescent QY was about 10%. 25 The key in this "TOPO-TOP" approach is a burst of nucleation which can be effectively separated from the growth process. 25 The use of highly flammable and toxic dimethylcadmium, however, limited the applicability of this approach at that time. Extensive efforts have been made to 30 develop and optimize this approach by using various stable and low toxicity precursors 26 (e.g. cadmium oxide, CdO; cadmium carboxylate, Cd(OOCR) 2 ; selenium oxide, SeO 2, etc.), non-coordinating solvents (e.g. 1-octadecene, ODE) and stabilizers 27 (e.g. octyldiphenylamine (ODPA), 35 diethylenetriaminepentaacetic acid (DTPA), hexadecyl amine (HDA), etc.) to generate monodisperse QDs with high QY. Monodisperse II-VI QDs with different sizes and shapes can be obtained by controlling their nucleation and growth processes through optimization of monomer concentration and reactivity, 40 molar ratio, reaction temperature, ligands, etc. (Figure 1 ). [28] [29] [30] [31] It has been found that slight modification of reaction parameters can lead to a broad variety of particle sizes and shapes. For example, Peng et al. demonstrated that the size and size distribution of CdSe dots can be manipulated by the monomer 45 concentration. 32 At high monomer concentrations, the smaller nanoparticles grow faster than larger ones, which results in the size distribution being "focused". If the monomer concentration drops below a critical threshold, the smaller particles are depleted as larger ones grow (i.e. Ostwald ripening), and the size 50 distribution gets broader or is "defocused". Controlling the nanoparticle growth kinetics can result in a narrow particle size distribution (5% standard deviation) without the sizeselective precipitation. 32 It was observed that the QY increased monotonically to 55 the maximum value and then decreased with the growth time. 33 Such a photoluminescence bright point indicates an optimal surface structure/reconstruction. Use of a large Se/Cd ratio (10/1) can result in very bright CdSe QDs with QY of 85% at room temperature. The high QY of these QDs is 60 attributed to stabilization of organic ligands on the surface. Since these ligands can be chemically degraded and detached from the surface, the photo-and chemical stability of the core is sometimes severely affected. In order to improve their luminescence and photostability, wide-band-gap shells (e.g. cadmium sulphide (CdS) and zinc sulphide (ZnS)) have been coated onto their surface to form core-shell QDs. 34, 35 Li et al.
developed a successive ion layer adsorption and reaction 5 (SILAR) technique to epitaxially grow shells in a noncoordinating solvent. 34 The resultant core-shell CdSe@CdS QDs had a QY of 40%. Xie and his co-workers further developed this approach to prepare CdSe-core-multishell QDs with QY up to 85%. 35 Recently, Chen et al. used cadmium oleate and 10 octanethiol as Cd-and S-precursors, and prepared nearly perfect core-shell CdSe@CdS QDs with the highest QY (97%) ever reported ( Figure 2 ). 36 The slow continuous precursor infusion and the relatively low reactivity of octanethiol provide optimal conditions for passivation of the 15 CdSe surface and growth of the CdS shell. Compared with conventional core-shell CdSe@CdS QDs, these new QDs featured significantly suppressed blinking, with an average fluorescence on/off time ratio of 94:6 for single large coreshell nanocrystals ( Figure 2 ). The blinking was gradually 20 suppressed with increasing shell thickness. 36 In addition to
Wurtzite core-shell CdSe@CdS QDs, zinc-blende core-shell analogues with suppressed blinking (>95% on time) were also prepared by Qin and co-workers. 37 These zinc blende core-shell CdSe@CdS QDs exhibited a QY of 90%. It should 25 be noted that non-blinking core-shell CdZnSe@ZnSe QDs, which exhibited complete suppression of blinking on the time scale from milliseconds to hours, were successfully prepared by Wang et al. 38 The high fluorescence QY and non-blinking QDs make them very useful in applications requiring a 30 continuous output of single photons. During the preparation of QDs, attempts to adjust the growth kinetics of the QDs incidentally led to the development of onedimensional (1D) nanorods. 29 By using very high precursor concentrations and a defined admixture of alkylphosphonic acids 35 and trioctylphosphine oxide (TOPO), 1D and even more complex structures such as arrows, teardrops, or tetrapods were synthesized ( Figure 1) . 30 Recently, we demonstrated that doped and undoped 1D semiconductor nanostructures can be produced by using a lower precursor concentration in the presence of 40 bismuth nanoparticles. [39] [40] [41] [42] [43] [44] This is in contrast to the synthesis of 1D nanostructures without nanocatalysts. These nanowires exhibited unusual optical, 45, 46 electronic, 47, 48 and magnetic 40 properties with potential diverse applications. 48, 49 The fast growth process resulted in crystal twinning and defects in the 45 nanowires, 50, 51 leading to a low fluorescence QY (< 1%) which could be improved by more than three times through coating with a wide-band-gap shell.
52
Despite monodispersity, high QY, and stability, these QDs generated in organic solvents are normally hydrophobic and 50 have to be modified in order to be water-soluble and biocompatible for bioapplications. The modification leads to the decrease in fluorescence QY, e.g. the QY of above perfect core-shell CdSe@CdS QDs decreased from 94% to 77% after transferred into PBS solution with PEG-SH. 36 55 Therefore, direct preparation of QDs in aqueous solution has been developed almost simultaneously.
The aqueous approach was firstly adopted by Henglein et al. to prepare CdS nanoclusters in 1982. 53 They also reported the first example of the preparation of CdTe QDs in aqueous 60 solution.
54
The resultant CdTe QDs did not show fluorescence, however. Rogach et al. synthesized stable fluorescent CdTe QDs with a QY of 3% by using thioglycerol and mercaptoethanol as stabilizers. 55 Later on, many efforts were made to improve QD fluorescence QY by using 65 different stabilizers (thioglycolic acid (TGA); mercaptopropionic acid (MPA)), precursor ratios, and manners of heating (hydrothermal and microwave methods). 56 Under the optimal conditions, the QY of watersoluble CdTe-based QDs can reach as high as 84%, which is 70 comparable to that of the above-mentioned hydrophobic QDs. High fluorescence QY also can be obtained by surface modification of as-synthesized QDs with illumination. For example, the fluorescence QY of CdTe QDs was drastically improved from 8% to 85% after 28-day illumination, due to 75 the formation of the core-shell structure (i.e. CdTe@CdS) with the assistance of illumination.
57
The above water-soluble QDs were normally prepared in strong basic solution (pH > 8), which limits their bioapplications, as most biological activities take place under 80 neutral-pH conditions. Adjusting the solution pH to neutral could quench the fluorescence of the QDs. Therefore, it is of great interest to develop a novel approach for preparing highly fluorescent water-soluble QDs from stable precursors under neutral pH conditions. Recently, we have successfully 85 synthesized highly fluorescent (84% QY) mercaptosuccinic acid (MSA)-capped CdTe/CdS QDs using stable Na 2 TeO 3 as the Te source via a one-pot reaction under neutral conditions ( Figure  3) . 58 A novelty of this approach is the use of MSA, which exhibits the features (pK COOH1 = 3.30, and pK COOH2 = 4. 59 This bioapproach is time-consuming (11 days), however, and the resultant QDs have a low fluorescence QY (8%), so this method cannot be used for large-scale preparation.
Surface modification of QDs
25
From the viewpoint of bioapplications, QDs should have excellent water-solubility, biocompatibility, and stability. These properties not only depend on their particle size, shape and composition, but also rely on their surface structure and surface charge. More importantly, the surface properties of QDs 30 determine their bio-interface interactions, cellular endocytosis and intracellular distribution, in vivo biodistributions, metabolism, and fate. [60] [61] [62] [63] Engineering surface of QDs therefore becomes highly important as this process can improve these properties and introduce additional functions. 10 71 The formation of single-dot@SiO 2 nanoparticles is attributed to the electrostatic repulsion between QDs and silica intermediates. 80 In order to improve the fluorescence QY and the number of QDs in each SiO 2 nanoparticle, we successfully prepared sandwich-like SiO 2 @CdTe@SiO 2 (SQS) nanoparticles using a novel strategy (Figure 4 ). 72 We started from the synthesis of the During the modification of QDs, the overall particle size has to be strictly controlled because it can dramatically influence the nanoparticle biological behaviour, such as cell internalization, tumour targeting and penetration, in vivo systemic and lymphatic 15 biodistribution, metabolism, and clearance. Nanoparticles with a size of 20-60 nm have shown distinct biodistribution, tumour penetration, and cellular tracking properties. 73 Therefore, we prepared a series of SQS nanopaticles with sizes in the range of 39 nm to 76 nm by controlling the reaction parameters, including 20 the amount and the type of silica precursor, the ratio of silica precursor to ammonia, and the ratio of H 2 O to surfactant. 74 These SQS nanoparticles exhibited strong size dependence of their stability, toxicity, and cellular uptake ( Figure 5 ). Our findings highlight the importance of controlling particle size and shell 25 thickness during the preparation of fluorescent QDs@SiO 2 coreshell nanoparticles.
Fluorescence imaging of QDs
The earliest bioapplications of fluorescent QDs were reported in 1998. 64 targeted QDs can accumulate within tumours through the enhanced permeability and retention (EPR) effect. Such passive targeting is attributed to the leakiness of the tumour vasculature and the poor lymphatic drainage, which enables QDs or other nanoparticles to accumulate in tumours. 75 The EPR effect could 60 lead to more than 50 times as great nanoparticle accumulation in tumours compared with healthy tissues. It is difficult, however, to maximize nanoparticle accumulation through the EPR effect, as this effect varies from tumour to tumour, and strongly depends on the particle size and the surface charge. 75 In addition, the EPR 65 effect is not commonly observed in some types of cancers such as gastric and pancreatic cancers. An alternative approach is active targeting, which can be achieved by conjugating QDs with targeting moieties such as small molecules (e.g. folic acid and hyaluronic acid), peptides 70 (e.g. arginine-glycine-aspartic acid (RGD)), and proteins (e.g. antibodies, antibody fragments, transferrin, etc.). 12 In 2004, Gao and colleagues reported a landmark work on in vivo cancer targeting with QDs ( Figure 6 ). 76 They first encapsulated hydrophobic CdSe@ZnS core-shell QDs with an ABC triblock 75 copolymer (i.e. polybutylacrylate-polyethylacrylatepolymethacrylic acid) by using hydrophobic-hydrophobic interactions between the capping ligands of QDs and the hydrophobic segments of the block copolymer. Then, they conjugated tumour-targeting ligands and drug-delivery functionalities with the polymethacrylic acid segment. The in vivo study showed that these QD probes accumulated at the 5 tumour site through the EPR effect, and the specific antibodyantigen interactions. It is worth mentioning that passive targeting is much slower and less efficient than active targeting.
Although targeted nanoparticles hold much promise, and the concept was introduced more than 30 years ago, none of them has 10 been clinically approved. 75 In addition to the high cost, the low targeting efficacy and the unclear mechanism could also limit their clinical applications. 35 This is because not all cancer cell types overexpress the same unique receptors, and the overexpressed receptors are often present on normal cells. 75 Moreover, the density of the targeted receptors on tumour cells could be another factor influencing the targeting efficacy. For II-VI QDs, the biggest challenge for their 40 clinical applications is their potential toxicity, as discussed in the following section.
QD toxicity
Most II-VI QDs consist of toxic elements such as cadmium, lead, mercury, etc. Their toxicity has always been of concern and 45 could limit the diversity of their applications, such as in solar cells, light-emitting diodes, flat-screen televisions, and biomarkers. 81 The bio-toxicity depends on multiple factors, 82 which can be mainly classified into two groups: (1) the inherent properties of QDs, including QD size, charge, composition, 50 concentration, and outer-layer coating bioactivity (capping material, functional groups); (2) environmental factors such as oxidation, photolysis, and mechanical effects. A number of studies show that appropriate surface modification, modulating the surface charge, and controlling the QD dosage can effectively 55 reduce QD cytotoxicity. Previously, we demonstrated that coating QDs with silica shells can improve their stability and reduce the toxicity ( Figure 5 ). 74 Some research has shown that the release of Cd 2+ and the oxidation products of anions are responsible for their bio-toxicity. 66 The QDs themselves (i.e. non-degraded QDs) 60 are not acutely toxic, and they can be retained in the body for two years and remain fluorescent. In 2007, Choi and co-workers studied the renal clearance of QDs. 83 They chose cationic, anionic, zwitterionic, and neutral molecules to modify CdSe@ZnS core-shell QDs and tested their 65 binding with serum proteins. They found that the QD surface charge has a profound effect on the adsorption of serum proteins and the hydrodynamic diameter. Cationic or anionic charge led to the hydrodynamic size increasing from around 5 nm to over 15 nm after incubation with serum. Neutral (PEGylated) QDs did not 70 aggregate, but had a large size. Zwitterionic coatings prevented serum protein adsorption and produced the smallest hydrodynamic size. The biodistribution results show that a final hydrodynamic diameter < 5.5 nm resulted in rapid and efficient urinary excretion and elimination of QDs. In their later report, the 75 authors conjugated small targeting molecules on the surface of zwitterionic coatings of QDs. 84 These targeted probes were also cleared by the kidneys when their hydrodynamic size was smaller than 5. 85 Their results demonstrated 85 that the acute toxicity of these QDs in vivo is minimal. Accumulation of an initial dose of Cd was found in the liver, spleen, and kidneys, however, even after 90 days, indicating slow breakdown and clearance of the QDs. Although QDs have not shown acute or short-term toxicity, comprehensive assessments 90 of their long-term bio-toxicity are needed to confirm the ultimate fate of these heavy metals and the impact of their persistence in primates for potential clinical use. 95 Since QDs have potential toxicity and long in vivo retention time, many efforts have been made to develop alternatives to them. An alternative is fluorescent metal nanoclusters, which have attracted considerable attention during the past several years. It is well known that large nanoparticles of metals such as Au, Ag, and Cu 100 possess the face-centred cubic (fcc) structure and the surface plasmon resonance (SPR) property. 86 Their SPR absorption is due to the collective oscillation of electrons on the surfaces, and it is strongly dependent on the particle size. When that size is smaller than the electron mean path (e.g. 20 nm for Au nanoparticles), the 105 conducting electrons in the ground states and excited states are confined. 86 The large metal nanoparticles have very low fluorescence emission. Very interestingly, when their size is further reduced below 2 nm, the ultra-small nanoclusters possess different crystal structures and exhibit strong photoluminescence 110 while their unique SPR property disappears. Nanoclusters bridge the gap between molecules and nanoparticles, and could simultaneously display the properties of both molecules and nanoparticles. Their novel optical, electronic, and catalytic activities make them very useful in ultrasensitive detection, biolabelling, bioimaging, and catalysis. [87] [88] [89] [90] The big challenge, however, is how to controllably synthesize metal nanoclusters with defined size, composition, crystal structure, and surface properties.
Fluorescent metal nanoclusters
88, 91 5 
Synthesis of fluorescent metal nanoclusters
Compared with large nanoparticles, metal nanoclusters are difficult to synthesize and functionalize because they only consist of a few to tens of metal atoms. ultraviolet (UV) to the near infrared (NIR) range with a QY from 10% to 70%. The latter experiments, however, proved that PAMAM dendrimers made a contribution to the solution fluorescence. The authors also used dendrimers as ligands to prepare fluorescent Ag nanoclusters. 89, 97 In addition to 45 dendrimers, some other polymers such as multiarm star polyglycerol-block-poly(acrylic acid) and DHLA functionalized PEG were used to stabilize metal nanoclusters.
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Recently, we used multidentate thioether-terminated poly(methacrylic acid) (PTMP-PMAA) (Figure 7(a) ) as ligand to 50 successfully prepare water-soluble fluorescent Au nanoclusters through reduction of HAuCl 4 with NaBH 4 . 100 Due to the strong steric effect, this polymer ligand has also been used to prepare ultra-small magnetic iron oxide nanoparticles. [101] [102] [103] [104] By controlling the polymer concentration and molecular weight, we 55 obtained a series of Au nanoclusters with emissions between 540 -800 nm and QYs of 2.6 -4.8%. In contrast to dendrimers, our polymer ligands did not show fluorescence, and the observed fluorescence was only caused by the Au nanoclusters. The different emissions of Au nanoclusters are attributed to their 60 different sizes. On the basis of this research, we prepared fluorescent Au, Ag, and Cu nanoclusters using photoreduction rather than chemical reduction (Figure 7(b) ). 105 Compared with PMAA, our polymer ligands have a stronger steric hindrance effect. Figure 7 (c) presents a typical transmission electron microscope (TEM) image of Au nanoclusters stabilized with PTMP-PMAA, clearly showing their ultra-small size (< 1.0 nm). In order to further investigate the polymer hindrance effect, 75 we designed three types of tridentate thioether-terminated polymer ligands, 107 i.e. poly(methyl methacrylate) (PTMP-PMMA), poly(n-butyl methacrylate) (PTMP-PBMA), and poly(tbutyl methacrylate) (PTMP-PtBMA), which were used to synthesize fluorescent Au nanoclusters through the facile photoreduction method. The resultant Au nanoclusters exhibited 5 blue fluorescence instead of red fluorescence due to their small particle size. Their QYs were found to be 3.8%, 14.3%, and 20.1%, respectively, which increases with increasing polymer steric hindrance, i.e. PTMP-PMMA < PTMP-PBMA < PTMPPtBMA. 10 In addition to polymer ligands, small thiol molecules such as glutathione, tiopronin, MPA, DHLA, phenylethylthiolate, and thiolate α-cyclodextrin were also used to prepare fluorescent metal nanoclusters. 87 nanoclusters with a QY of 15%. 109 They proposed that strong luminescence emission is attributed to aggregation-induced emission of Au(I)-thiolate complexes. The QYs of metal nanoclusters stabilized by small molecules are similar to those nanoclusters stabilized with polymer. 20 In order to improve the biocompatibility of fluorescent metal nanoclusters, several groups used biomolecules such as oligonucleotides, peptides, and proteins as stabilizers during preparation. [110] [111] [112] [113] For example, the Dickson group took advantage of the strong affinity of Ag + to cytosine bases from 25 single-stranded DNA, and prepared very small Ag nanoclusters using DNA as stabilizer. 110 In their later report, they used DNA microarrays for high-throughput analysis of 12-mer strands to identify optimized sequences for Ag encapsulation, and produced five distinct Ag emitters with QYs in the range of 16 -34%. Etching of large metal nanoparticles is an alternative approach to prepare fluorescent metal nanoclusters. (Figure 8 ).
117
In addition to small molecules, multivalent polymers can also be used as etching agents. Duan et al. used multivalent polyethylenimine (PEI) to etch 8 nm Au nanoparticles, which 70 were prepared by a two-phase approach and stabilized with dodecylamine. The resultant cluster solution surprisingly appeared to be in an oxidized electronic state with an emission at 505 nm. The emission was blue shifted to 445 nm with a QY of 10 -20% after reduction with NaBH 4 .
118 75 Similar to organic ligands, metal precursors can also induce the etching process. For example, Lin and co-workers extracted HAuCl 4 from aqueous solution into didodecyldimethylammonium bromide (DDAB) toluene solution, and then added the mixture into 5.6 nm Au solution to result in 80 3.2 nm particles. 119 After replaced DDAB with dihydrolipoic acid, these Au nanoparticles were further decreased to 1.6 nm and showed a red emission around 700 nm. Their fluorescence QY was 3.4% in methanol and 1.8% in water (pH = 9 18 and Au 38 (SR) 24 nanoclusters, and found a similar core-shell structure. 91 An Au 25 (SR) 18 cluster consists of an icosahedral Au 13 core and exterior 12 Au atoms in 55 the form of six -RS-Au-RS-Au-RS-motifs.
91, 108
The ultra-small size (limited atomic numbers) of metal nanoclusters makes it possible to predict their crystal structures through precise theoretical simulation. In order to demonstrate the origin of multiband absorption, Zhu and co-workers chose the Au 25 (SR) 18 cluster as a model and simulated their absorption by performing time-dependent DFT calculations.
131 Figure 9 (a) shows the Kohn-Sham molecular 85 orbitals, energies, and atomic orbital contributions in the cluster. The highest occupied molecular orbital (HOMO) and the lowest three lowest unoccupied molecular orbitals (LUMOs) are mainly composed of 6sp atomic orbitals of Au, and these orbitals constitute the sp-band. The HOMO-1 to HOMO-5 orbitals are 90 constructed from the 5d atomic orbitals of Au and form the dband. In addition, the s 3p orbitals make contributions to both sets of HOMO and LUMO orbitals. The multiband absorption of metal nanoclusters suggests their multiple emission peaks and broad fluorescence spectra (Figure 9(b) ). Figure 9( results show that the luminescence of these core-shell nanoclusters was generated by the aggregation-induced emission of Au(I)-thiolate complexes on the nanocluster surface. The fluorescence of metal nanoclusters is very sensitive to the cluster size, surface ligands, solvents, etc., so it is thus necessary 25 to modify them in order to maintain their bright fluorescence in addition to improving their stability and biocompatibility. There are few reports, however, on the post-modification of fluorescent metal nanoclusters in comparison with large nanoparticles, due to their tiny size and sensitivity to external conditions. Lin and co- 30 workers prepared DHLA-protected fluorescent Au nanoclusters by etching large nanoparticles and replacing surface ligands. 119 They took advantage of carboxylic acid groups from DHLA to conjugate PEG-NH 2 or biotin-PEG-NH 2 with Au nanoclusters. The gel electrophoresis and the cell labelling indicate the 35 successful conjugation. Samanta et al. prepared fluorescent Au nanoclusters using a novel quaternary ammonium as the ligand, and then coated them with silica. 134 Similar to fluorescent QDs, surface modification can lead to the fluorescence quenching of metal nanoclusters. It is still a great challenge to obtain robust 40 fluorescent metal nanoclusters through surface modification.
Application of fluorescent metal nanoclusters in bioimaging
Similar to other fluorophores, fluorescent metal nanoclusters have also been tested for in vitro and in vivo bioimaging. In the early reports, Zheng et al. prepared fluorescent Au, Ag nanoclusters in 45 the presence of dendrimers, DNA, and proteins, and used them as labels for cell imaging.
89, 94-97 Baskov et al. prepared fluorescent
Ag nanoclusters in the presence of thioflavin T with remarkable fluorescent properties, 135 and then used them to label amyloid fibrils produced from recombinant mammalian prion proteins and 50 non-prion proteins. The labelled amyloid fibrils exhibited a timedependent increase in fluorescence with no photobleaching after 24-h illumination, while those stained with thioflavin T showed a rapid decay in fluorescence. Their results demonstrate the higher stability of Ag nanoclusters than that of organic fluorophore. 55 Recently, we prepared fluorescent Au nanoclusters stabilized with PTMP-PMAA, and then compared them with CdTe QDs in labelling suspended and adherent hematopoietic relatively normal cord blood mononuclear (CBMC) cells and cancer K562 cells (Figure 10) . 100 The results show that the cancer cells took up 60 more Au nanoclusters than the normal cells, even though they were from the same hematopoietic system. There was no difference, however, in the uptake of CdTe QDs between the two kinds of cells. 25 clusters were found to be internalized in significantly higher concentrations compared to the negative control cell lines. 136 Apart from routine utilization of cell labelling, fluorescent metal nanoclusters can be used as 137 and found that the uptake of NIR Au nanoclusters by the reticuloendothelial system was relatively low in comparison with other nanoparticles due to their ultra-small 10 hydrodynamic size (~2.7 nm). They then used MDA-MB-453 and xenografted HeLa tumour cells as models to do in vivo and ex vivo imaging studies, and found that the ultra-small Au nanoclusters were highly accumulated in the tumour areas due to the enhanced permeability and retention (EPR) effect.
137 15 Zhou and co-workers studied the renal clearance of 2 nm glutathione (GSH)-coated fluorescent Au nanoclusters ( Figure  12 ), 138 and found that only ~4% of the particles were accumulated in the liver, while more than 50% of the particles were found in urine within 24 h after intravenous injection, which is comparable 20 to the QDs with the best renal clearance efficiency. 83 They also used computed tomography (CT) to visualize real time accumulation of luminescent GS-AuNPs in the bladder, and demonstrated that fluorescent Au nanoclusters can serve as contrast agents for CT imaging ( Figure 12 ). Recently, they 25 compared GSH-coated fluorescent Au nanoclusters (2.5 nm) with small dye molecules IRDye 800CW, 139 and found that they both have similar physiological stability and renal clearance, but Au nanoclusters exhibited a much longer tumour retention time and faster normal tissue clearance ( Figure 12 ). These merits enabled 30 the Au nanoclusters to detect the tumour more rapidly than the dye molecules without severe accumulation in reticuloendothelial system organs.
139
Besides the above in vivo passive targeting, fluorescent metal nanoclusters can be tagged with bioactive molecules for targeting, 35 imaging, and therapy. For example, Liu et al. synthesized fluorescent Au nanoclusters (0.92 ± 0.03 nm) using insulin as a template. 113 The resulting Au-insulin nanoclusters retain the insulin bioactivity and biocompatibility, and have been used to regulate the in vivo glucose level in Wistar rats. The results show 40 that an injection of insulin-Au nanoclusters into the rats tended to reduce the blood glucose in a similar way to commercial insulin. Fluorescent insulin-Au nanoclusters can also be used as contrast agents for CT imaging. 113 These studies indicate that ultra-small fluorescent Au nanoclusters could simultaneously serve as very 45 promising contrast agents for in vivo fluorescence imaging and CT imaging. In summary, fluorescent metal nanoclusters as emerging fluorophores have attracted considerable attention due to their tuneable emissions, ultra-small size, fast renal clearance, and low 50 toxicity. There are a few obstacles to be overcome, however, including (i) low fluorescence QY, which is usually about ~10% and less than that of QDs and many organic dyes; (ii) polydispersity in size and components, which makes it very difficult to fundamentally study their novel properties and 55 mechanisms; (iii) difficulty in modifying their surface to introduce other functions due to their tiny size and lower stability; (iv) complicated interactions with biological environments. 60 PEG to get fluorescent carbon dots with a fluorescence QY of 4% -10%. 142 The photoluminescence of these carbon dots was broad and strongly dependent on the excitation wavelength, which could be attributed to the different sizes in the sample and different emission sites on the passivated particle surfaces. After hydrophilic carbon dots with tuneable size and visible emissions, 144 by dehydrating carbohydrate in octadecene in the presence of octadecylamine, or in concentrated sulphuric acid ( Figure 13 ). Their method produced gram-scale fluorescent carbon dots with a QY of 6 -30%. Zhu and co-workers also 10 reported a rapid and high-output hydrothermal approach to prepare polymer-like carbon dots with QYs as high as 80 %.
Fluorescent carbon nanomaterials
Fluorescent carbon dots
145
In addition to solid fluorescent carbon dots, there are some reports on hollow fluorescent carbon dots. 146 pentoxide to obtain cross-linked hollow fluorescent carbon nanoparticles. By reducing the release of heat, they also obtained solid fluorescent nanoparticles. So far, many approaches, such as arc-discharge, laser ablation, electrochemical oxidation, combustion/pyrolysis, and hydrothermal and microwave 20 methods, have been developed to prepare solid and hollow fluorescent carbon dots. 148 The preparation is inexpensive on a large scale without the need for stringent, intricate, tedious, costly, or inefficient steps. 149 The recent advances in the synthesis and characterization of fluorescent carbon dots have been 25 reviewed.
17, 148, 149
The first study of fluorescent carbon dots in bioimaging was reported by the Sun group in 2007. 150 The authors used poly-(propionylethylenimine-co-ethylenimine) (PPEI-EI, with EI fraction ~20%) to modify the carbon dots, and then applied them 30 to label human breast cancer MCF-7 cells. These labelled cells exhibited bright fluorescence in both cell membrane and cytoplasm regions under an excitation of 800-nm laser pulses.
The results demonstrate that carbon dots exhibit strong luminescence with two-photon excitation in the near-infrared, and 35 moreover, large two-photon absorption cross-sections, comparable to those of available high-performance semiconductor QDs. 150 The authors further demonstrated the in vivo imaging of fluorescent carbon dots.
151 They compared the imaging capability of carbon dots and ZnS-doped carbon dots, 40 and found that the later dots emitted more strongly than the former dots both in solution and in mice. The fluorescence from the bladder area was observed, and 3 h after injection, the fluorescence could be detected in the urine, but it completely faded 24 h after injection. They analysed the biodistribution of 45 carbon dots and found that the carbon dots accumulated in the kidney and, to a small extent, in the liver. 151 This is attributed to the surface PEG, which likely reduces the protein adsorption. Recently Huang and co-workers investigated the effects of injection routes on the biodistribution, clearance, and tumour 50 uptake of carbon dots (Figure 14) . 152 They prepared fluorescent carbon dots through a laser ablation approach, and then functionalized carbon dots with the NIR dye ZW-800 and the isotope 64 Cu. They injected the conjugates into mice in three different manners, i.e. intravenous, intramuscular, and 55 subcutaneous injection. The results show that the carbon dots were efficiently and rapidly excreted from body after injection, and the clearance rate of carbon dots decreased when the administration was varied from intravenous, to intramuscular, and then to subcutaneous injection ( Figure 14) . Different injection 60 routes also showed different blood clearance patterns and different tumour uptake of carbon dots.
Fluorescent graphene quantum dots
It should be noted that fluorescent graphene quantum dots (GQDs), the analogues of carbon dots, have also attracted 65 considerable attention. 153, 154 Similar to carbon dots, GQDs can be prepared by top-down and bottom-up approaches, and their fluorescence can be enhanced via surface modification. The topdown methods usually refer to cutting larger size carbon and then transferred the suspension into Teflon autoclaves and treated them at high temperature for a few hours to get GQDs with a QY of 11%. 155, 156 Tetsuka and co-workers used the hydrothermal approach to treat graphene oxide sheets in ammonia solution to get GQDs with a QY between ~19 -29%. 157 The 10 emission of GQDs can be tuned by controlling the hydrothermal temperature ( Figure 15(a) ), and the QYs can be further enhanced to ~46% after modification with PEG. Wu et al. used a one-step pyrolysis of a natural amino acid (i.e. glutamic acid) to prepare fluorescent GQDs with a QY of 54.5%. 158 Recently, Dong and 15 co-workers used L-cysteine as precursor to prepare S,N-co-doped GQDs with a QY up to 73%, 159 which is the highest value reported so far. The preparation process significantly influences the optical properties of GQDs. There are two types of emissions in GQDs, 20 i.e. intrinsic state emission and defect state emissions ( Figure  15(b) ). 160 The competition between these two states could be changed during preparation or post surface modification. For example, Zhuo and colleagues oxidized graphene in concentrated H 2 SO 4 and HNO 3 , and then sonicated the mixture and calcinated 25 it at 350 ˚C to remove acid. 161 The resultant fluorescent GQDs did not exhibit excitation-dependent fluorescence [ Figure 15(cd) ]. 161 However, Zhu et al. prepared green fluorescent GQDs through the hydrothermal approach. 155 The green fluorescence was changed into blue after the GQDs were modified with 30 alkylamines or reduced with NaBH 4 (referred to as m-GQDs and r-GQDs respectively), while the particle size was similar. The fluorescence shift was attributed to the suppression of nonradiative processes and to the enhanced integrity of the π conjugated system. These three types of GQDs exhibited strong 35 excitation-dependent down-conversion and up-conversion emissions, demonstrated by that of the m-GQDs in Figure 15 (ef), 155 which is in contrast to Zhuo's report [ Figure 15(c-d) ]. In addition to the preparation, the optical properties of GQDs are also influenced by the solution pH, solvent, and concentration.
154 40 Recently, Xu et al. studied the fluorescence of GQDs on a substrate at the single particle level. 160 All the GQDs investigated had the same spectral lineshapes and peak positions, despite notable differences in particle size and the number of layers. GQDs with more layers were brighter than those with fewer 45 layers, but were associated with shorter fluorescence lifetimes. Although there are some debates on the fluorescence mechanisms of GQDs, their unique properties afford many applications in cellular and deep-tissue imaging. Sun and coworkers demonstrated the first bioapplication of nanographene 50 oxide (NGO), 162 i.e., single-layer graphene oxide sheets a few nanometers in lateral width. The PEGylated NGO sheets used were soluble in buffers and serum without agglomeration, and showed photoluminescence in the visible and infrared regions. These NGO sheets had low background photoluminescence in the 55 near-infrared (NIR) window. In addition, simple physisorption through π-stacking was used to load the anticancer drug doxorubicin onto NGO functionalized with antibody for selective killing of cancer cells in vitro. 162 Compared with fluorescent carbon dots, GQDs can be used for 60 two-photon or multi-photon luminescence imaging. 163, 164 Qian et al. used PEGylated graphene oxide nanoparticles to label HeLa cells, 163 and observed that graphene oxide nanoparticles were mainly localized in the mitochondria, endoplasmic reticulum, Golgi apparatus, and lysosomes of HeLa cells with a two-photon 65 scanning microscope. They intravenously injected graphene oxide nanoparticles into mouse bodies from the tail vein, and observed their flow, distribution, and clearance in the blood vessels, utilizing a deep-penetrating two-photon imaging technique. These nanoparticles were also injected into the brains 70 of gene transfected mice, and the in vivo two-photon luminescence imaging results showed that graphene oxide nanoparticles were located at 300 µm depth in the brain, They also demonstrated a large imaging depth of 1800 μm by a study of penetration depth in tissue phantom ( Figure 16 ). In summary, surface-modified fluorescent carbon nanomaterials (carbon dots and GQDs) have small size, distinctive photoluminescence properties, low toxicity, and low 10 cost. These advantages offer them great potential for optical imaging and biomedical applications, as they might gradually replace conventional semiconductor QDs in these aspects.
5 Ultra-small up-conversion nanocrystals 15 Compared with previously mentioned fluorescent nanomaterials, up-conversion nanostructures, especially lanthanide-doped nanocrystals, have distinct advantages in fluorescence bioimaging, such as low autofluorescence background, large antiStokes shifts, sharp emission bandwidth, high resistance to 20 photobleaching, and high penetration depth and temporal resolution, [165] [166] [167] [168] [169] [170] [171] In addition, they can be used for multimodal bioimaging and therapy ( Figure 17 ). More bioapplications of upconversion nanoparticles can be found in recent reviews. 165, [169] [170] [171] However, they usually have a larger size in comparison with 25 those nanoprobes described previously (i.e. QDs, metal nanoclusters, carbon dots, and GQDs). There are few reports on ultra-small up-conversion nanoparticles, especially those below 5 nm. [172] [173] [174] [175] [176] [177] Herein we mainly introduce the fundamentals of upconversion nanoparticles and the progress in preparation and 30 imaging application of ultra-small nanoparticles. For up-conversion nanocrystals, their emission process involves the sequential absorption of two or more photons, which is fundamentally different from the multi-photon process, where the absorption of photons takes place simultaneously. There are 35 three types of up-conversion mechanisms, i.e. excited state absorption (ESA), energy transfer up-conversion (ETU), and photon avalanche. 166 The up-conversion nanocrystals usually consist of activators, sensitizers, and the host matrix [ Figure  17( activators, and the molar ratio between activators and sensitizers is usually kept low to avoid the quenching effect. 166 Zhao et al.,
however, showed that up-conversion luminescence can be significantly enhanced by using much higher activator concentrations (e.g. 8 mol% Tm 3+ in NaYF 4 ) under relatively 55 high-irradiance excitation. 178 The authors attributed the high brightness to a combination of high excitation intensity, increased activator concentration, and accelerated sensitizer-activator energy transfer rate arising from the decreased average minimum distance between adjacent lanthanide ions. The high brightness 60 makes it possible to remotely track a single nanocrystal with a microstructured optical-fibre dip sensor. 178 Ideal host materials should have low lattice phonon energy and the minimum lattice mismatch with dopants (activators and sensitizers). Rare-earth fluorides are generally chosen as host 65 materials, as rare-earth ions have similar ionic size and chemical properties to lanthanide ions, and their fluorides exhibit low phonon energy and high chemical stability. 166 In particular, NaGdF 4 is extensively used as it can serve as a positive contrast agent for magnetic resonance imaging (MRI general and versatile approach to fine-tune the multicolour emissions over a broad range with single wavelength excitation. 180 By introducing Gd 3+ during preparation, the authors simultaneously controlled the crystal phase, particle size, and optical properties of the resultant nanocrystals. 181 Recently, a 90 core-shell structure with a set of lanthanide ions incorporated into separated layers was designed. The core-shell structure can minimize the deleterious effects of cross-relaxation. The bright up-conversion emission was achieved through Gd 3+ mediated energy migration without long-lived intermediate energy 95 states.
182, 183
In up-conversion nanoparticles, minimizing the depletion of excitation energy is the key to tuning their luminescence. The excitation energy can randomly migrate from an atom to its neighbouring atoms that are isotropically distributed in a 3D 100 structured crystal sublattice (type I in Figure 18 ). This energy can also migrate in a crystal with a 2D layer structure (type II), or in a crystal featuring a 1D atomic chain structure (type III). This allows to minimize the concentration quenching of the luminescence, and generates an unusual four-photon-promoted 5 violet up-conversion emission from KYb 2 F 7 :Er (2 mol%) with an intensity more than eight times higher than that previously reported. 184 The approach of enhancing up-conversion through energy clustering at the sublattice level may provide new opportunities to engineer up-conversion nanoparticles for diverse 10 applications. The good understanding of the energy migration, luminescence mechanism, and the recent advances in wet chemistry have enabled the fine-tuning of particle size (even in the small size range), crystal structure, surface functionalities, and optical 15 properties of up-conversion nanocrystals for bioimaging, drug delivery, and sensing. 165, 167, 169 Their fluorescence has been applied to image cells and small animals. 185 As mentioned previously, Gd-based up-conversion nanoparticles are particularly interesting as they can serve as fluorescent nanoprobes and 20 contrast agents of MRI simultaneously. Recently, a multifunctional drug delivery system combining up-conversion luminescence/magnetic resonance/computer tomography trimodality imaging and NIR-activated platinum pro-drug delivery has been developed by Dai and co-workers ( Figure   25 19). 186 Organic-soluble core−shell nanoparticles were first prepared by complex thermal decomposition method, followed by surface modification and conjugation with the trans-platinum (IV) pro-drug. The up-conversion nanoparticles can not only 30 deliver the platinum (IV) pro-drugs into the cells effectively, but convert near-infrared light into UV to activate pro-drug as well. Meanwhile, they can further serve as contrast agents for multimodality imaging to guide cancer treatment. The pro-drugconjugated nanoparticles under near-infrared irradiation led to 35 better inhibition of tumor growth than that under direct UV irradiation in the mouse test. 186 Such multifunctional upconversion nanoparticles have been a subject of intensive research due to their potential in disease diagnosis and treatment. 165, 170 40 For in-vivo bioapplications, one of the major issues for upconversion nanocrystals is the fate of nanoparticles and potential toxicity of lanthanide ions. . 189 The accumulation of both types of nanoparticles in liver decreased with the circulation time. In contrast, their accumulation in spleen increased with the circulation time. This suggests that both of these nanoparticles may be eliminated through the biliary 50 pathway. Analysis of urine collected at different time points indicates that renal clearance was one of the major elimination pathways for 5.1-nm particles, but not for 18.5-nm particles. Further analysis on faces by TEM shows that these particles do not change in shape and size, suggesting the high stability of up- 55 conversion nanoparticles in vivo.
189
Although up-conversion nanoparticles do not show acute toxicity at the cell or animal level, it is necessary to investigate their long-term toxicity. Another drawback of up-conversion nanocrystals is the low quantum yield (usually less than 1%) in 60 comparison with other fluorescent agents. 165 Preparation of highly efficient up-conversion nanocrystals remains a great challenge.
6 Fluorescent silicon nanoparticles 65 Fluorescent silicon nanoparticles (Si NPs) have also attracted considerable attention in bioapplications due to their excellent biocompatibility as silicon naturally exists in human body as a trace element. 18, 20, 190 18, [190] [191] [192] [193] These Si NPs are usually functionalized with hydrophobic ligands such as styrene, alkyl, and octene. They are photochemically 10 stable in non-polar solvents up to 1 year. 192 For example, hightemperature thermal processing of the sol-gel precursor derived from trichlorosilane (HSiCl 3 ) produced Si NPs embedded within the SiO 2 matrix. 191, 194 Si NPs were released after etching the SiO 2 matrix with HF, and then passivated with allylbenzene through 15 the thermally initiated hydrosilylation reaction. The resultant colloidal Si NPs were fractionated by size selective precipitation to obtain monodisperse nanoparticles, which showed strong quantum confinement effects and size-dependent absolute QYs (Figure 21 ). 191 The absolute QYs increased with particle size up 20 to 43%. During preparation, Si NPs can be chemically doped to introduce other functions. 195, 196 Paramagnetic fluorescent Si NPs were prepared by solvothermal decomposition of Mn-doped sodium silicide. 195 The 196 The use of reactive sodium silicide makes their control preparation difficult 30 and could limit their broad applications, and thus development of novel preparation approaches is necessary. Similar to carbon dots and GQDs, Si NPs produced from different methods seem identical, but their optical properties are dramatically different. For example, the Si NPs prepared with 35 high-temperature method routinely exhibit photoluminescence agreeing with the effective mass approximation (EMA), while those prepared via solution methods exhibit blue emission somewhat independent of particle size. 197, 198 Recently, Dasog et al. prepared Si NPs using three most widely cited procedures (i.e. 40 etching of annealed SiO x , reduction of SiCl 4 , and solvothermal reaction of sodium silicide with NH 4 Br), 197 and found their conversion of red-fluorescence to blue emission. Their findings suggest that the presence of trace nitrogen and oxygen even at the ppm level in Si NPs gives rise to the blue emission, and support 45 the hypothesis that the nitrogen defect or impurity site contributes to the blue emission. 197 In order to apply Si NPs to bioimaging, tremendous efforts have been made to prepare water-soluble and biocompatible Si NPs through simple and efficient methods. [199] [200] [201] [202] [203] [204] [205] For example, Si 50 NPs with excellent aqueous dispersibility, robust photo-and pHstability, strong fluorescence ( 15%), and favorable size ( 4 nm) are facilely and rapidly prepared from Si nanowires and glutaric acid in a short reaction time (e.g., 15 min) by He and coworkers. 202 These Si NPs are particularly suitable for long-term and real-time cellular imaging due to their higher photostability than II-VI QDs and dyes (e.g. CdTe QDs and FITC). Distinctive red fluorescence of Si NPs can be retained throughout 240-min 5 irradiation. In contrast, the green fluorescence of FITC rapidly diminishes in 3 min due to severe photo bleaching, and the red signals of CdTe QDs nearly vanishes after 25-min irradiation. The MTT assays showed negligible cellular toxicity to HeLa cells, demonstrating the excellent biocompatibility of Si NPs. 10 Furthering their research, the authors used (3-aminopropyl)trimethoxylsiliane as precursor and prepared 2.2 nm Si NPs by the similar method. 204 The obtained Si NPs exhibited strong green fluorescence with a QY of 20-25%, biocompatibility, and robust photo-and pH-stability. As shown in NP-labelled nuclei retained stable fluorescence during observation for 60 min, however the fluorescence from FITC labels drastically decreased in 3 min due to severe photo bleaching. In addition to in vitro labelling cells, Si NPs can also be used 30 in multiple cancer-related in vivo applications, including tumor vasculature targeting, sentinel lymph node mapping, and multicolor NIR imaging in live mice. 206 Erogbogbo and coworkers demonstrated that Si NPs can overcome dispersibility and functionalization challenges for in vivo imaging through 35 surface functionalization, PEGylated micelle encapsulation, and bioconjugation process, which produced bright, targeted nanospheres with stable luminescence and long (>40 h) tumor accumulation time in vivo. Recently, the biodistribution and toxicity of Si NPs in mice and monkeys have been assessed 40 ( Figure 23 ). 207 The top images in Figure 23 show the biodistribution of Si NPs in mice, the fluorescence image of frozen tissue sections, and the confocal images, which clearly reveals particles localized in the liver, spleen, and kidneys after injection. The ICP-MS data show notable increase of silicon 45 levels in the liver, spleen, lung, kidneys, and lymph. The concentration of silicon in the lymph and kidneys declined over the 14-week time period, while the liver and spleen retained a significant fraction of the silicon injected, even after 14 weeks. 207 There is no evidence of the biodegradability of silicon NPs. The 50 bottom images in Figure 23 display the histological images of the brain, cerebellum, atrium, ventricle, heart muscle, lung, kidney, liver, spleen, renal tubule, intestine, lymph nodes, and skin of the rhesus macaques. 207 There was no sign of nanoparticle-induced changes in these organs and tissues. This research indicates 55 neither mice nor monkeys showed overt signs of toxicity reflected in their behavior, body mass, or blood chemistry. The biodistribution of Si NPs in mice was also quantitatively evaluated by in vivo positron emission tomography (PET) imaging and ex vivo gamma counting. 208 A new macrocyclic 60 ligand- 64 Cu 2+ complex was conjugated with dextran-coated Si
NPs and served as PET agent. The results show that conjugates were excreted via renal filtration shortly post injection and also accumulated in the liver, again demonstrating the stability and biocompatibility of Si NPs. 65 In summary, Si NPs have tuneable fluorescence from visible to near-infrared window, excellent biocompatibility, chemical, and photostability. These properties make them very attractive in bioimaging, however long-term studies on their safety and adverse effects are still needed for their clinical applications. 70 
Summary and outlook
We have summarized the current state of the art on ultra-small inorganic nanoparticles for fluorescence bioimaging. These ultrasmall nanoparticles bridge the gap between big particles and molecules. They have unique properties and great potential in molecular imaging for diagnosis and treatment of cancer and other diseases, as they could escape from macrophages, pass biological barriers, and be easily degraded or excreted in comparison with large particles.
The ultra-small fluorescent probes we addressed include the 5 conventional QDs, fluorescent metal nanoclusters, carbon-based nanomaterials, up-conversion nanocrystals, and silicon nanoparticles. The fluorescence mechanisms in metal nanoclusters, carbon dots, and graphene quantum dots are not completely clear as yet. Although they can be prepared by 10 various wet chemistry methods, it remains a challenge to prepare robust fluorescent probes with high photostability (i.e. nonblinking), chemical stability, high quantum yield, and tunable emissions in the visible to NIR window. From the applications perspective, some of them face the issue of toxicity, especially 15 semiconducting QDs and up-conversion nanocrystals, as they have toxic elements such as cadmium and lanthanides. Various approaches and coatings have been developed to modify and functionalize their surfaces to overcome these shortcomings. In addition to the issues of fluorescent nanoprobes themselves, there 20 are some important issues that have to be considered for practical applications, including their interactions with proteins and other biomolecules, their interactions with cells, their endocytosis and intracellular stability and behaviour, and their metabolism and excretion. These issues have not been well understood, despite 25 some progresses on bio-interface interactions in the biological environments have been made in recent years.
61-63
The use of fluorescence imaging alone could lead to inaccurate diagnosis or misdiagnosis, due to the low spatial and temporal resolution, and the sensitivity of fluorescence to external 30 environments. Simultaneous use of multi-modal imaging (e.g. magneto-fluorescence) could overcome the disadvantages of individual methods. There are increasing reports on the combination of fluorescence with other imaging methods such as MRI, CT, and PET. 60, [209] [210] [211] [212] There are few commercial 35 multifunctional instruments for multimodal imaging, however. Relocating biological samples between different imaging instruments could lead to inaccuracy. 213 Development of multimodal imaging that employs a single instrument is an attractive solution. 213 In addition, incorporation of therapeutics 40 into multimodal nano-agents for early detection and treatment will be an important feature of future nanotheranostics. 
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